Resmed

$251.21 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Resmed

ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD), neuromuscular disease and other diseases. The Company operates through two segments: Sleep and Respiratory Care segment, and the Software-as-a-Service (SaaS) segment. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. Its cloud-based software digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions.

Stock Analysis

last close $255
1-mo return -4.7%
3-mo return -9.7%
avg daily vol. 495.68T
52-week high 301.34
52-week low 179.37
market cap. $37.9B
forward pe 39.5
annual div. 1.68
roe 17.5%
ltg forecast 23.3%
dividend yield 0.66%
annual rev. $3.3B
inst own. 67.5%
baraka

Subscribe now for daily local and international financial news

Subscribe